fda warning letters compounded tirzepatide 2024 2025 Drug Recalls and Warnings: Recalls for Semaglutide and Tirzepatide, Wegovy; Facility FDA Issues Warnings Against Illegal

Two medications generating significant attention are tesofensine and semaglutide compounds that achieve weight loss through fundamentally different biological mechanisms

Liraglutide restores impaired associative learning in individuals with obesity

Clinical trial data from the SURMOUNT-1 study showed that participants on 5mg weekly lost an average of 15% of their body weight over 72 weeks

Dehydration from persistent vomiting or diarrhea represents a serious concern requiring prompt evaluation, especially in patients with renal impairment or those taking other medications affecting fluid balance

I wont get my meds anywhere else

If you can access one medication for 3 months but then need to switch to the other due to cost or availability, having a safe transition protocol makes the alternating inevitable rather than optional